Prime Fund Recommendation: A high-risk, off-beat equity fund

The traditional mutual fund categories of large-cap, flexicap, midcap or smallcap will always find place in a portfolio. But once you’re done with introducing style diversity through growth or value funds from these categories, where can you go if you want to add other differentiators? 

One way is to look at less homogenous categories. Here, the thematic category presents an eclectic collection of funds. While many of these thematic funds are new, they offer differentiation and are therefore worth a look. 

We already have two of these in Prime Funds – ICICI Pru India Opportunities and Franklin India Opportunities. In the recent Prime Funds review, we identified and added one more – White Oak Capital Special Opportunities under the High Risk Turnarounds category. 

This is an out-of-the-ordinary call for us, given that the fund was launched only in June 2024. The reasons were as follows:

  • The fund’s differentiated strategy and portfolio with low overlaps between other funds and the Nifty 500 index
  • The very strong performance it has clocked since its inception, compared to both older, more established funds as well as fellow new funds.
  • Strategy of locking into profits or trimming losses through active churn of the portfolio, and its ability to tap into short term stock price moves
  • The need for investors to tap into fresh opportunities ahead of time, without waiting for a long track record to establish. In the current range-bound market, where stock and sector shifts are swift, it is important to include a variety of funds in the portfolio to get above-market returns.

But why this particular fund? Here’s the rationale. 

Defining special opportunities

White Oak Capital Special Opportunities (WOC Special Opportunities) is classified under the thematic category. The ‘theme’ here is special opportunities, which loosely translates into stocks going through a unique situation or challenge. The fund tries to swoop in stocks where prices have declined or valuations are supressed due to a unique situation or event. 

Every fund playing on this theme has a different definition of what constitutes a special situation. For WOC Special Opportunities, it means the following:

  • Corporate restructuring or events such as mergers & acquisitions, stock splits and other corporate actions etc
  • Regulatory changes or geopolitical issues
  • Sector disruptions or emerging trends/sectors 
  • Other temporary challenging situations a company or a sector might find itself in, but which do not structurally alter its business potential

Naturally, such a strategy will require a stock-specific approach. WOC Special Opportunities is benchmark-agnostic and invests across market capitalisations. 

Dynamic portfolio shifts

The fund’s marketcap allocation has been skewed towards the mid and smallcap segment which makes up about half the portfolio. This is in line with peers such as Franklin India Opportunities or ABSL Special Opportunities, but is much higher than ICICI Pru India Opportunities.

In its stock allocations, WOC Special Opportunities is extremely diversified with over 50-70 stocks. Top holdings are also not too concentrated, with the top 20 typically making up about half the portfolio. The fund, therefore, sports a very long ‘tail’ of stocks with small allocations to each. The table below shows the top 20 stocks currently in its August portfolio.

This strategy of starting with small allocations can have two benefits. One, the fund can take advantage of more opportunities. For example, a bet on a stock such as KRN Heat Exchanger could be to ride the temporary euphoria post the company’s IPO, Bharat Dynamics could be a bet on the surge in interest in defence stocks earlier this year. Two, it reduces the risk of calls going wrong, since a ‘special situation’ call is probabilistic in nature and may not play out as expected.

The fund’s portfolio moves also do not suggest a buy-and-hold approach. It is extremely active on multiple fronts. It frequently trims exposure in stocks to book profits and realize gains. It gradually builds up positions in some sectors or stocks. It also trims exposure or entirely exits stocks to cut losses, which is a plus given the very high risk nature of its strategy and the enormous portfolio it owns.  

Between the June and August portfolios, the fund reduced allocations in over 45 stocks while increasing allocations in 28. It booked profits in stocks such as Hitachi Energy, Cholamandalam Finance, Kotak Mahindra Bank, Lumar Auto Technologies etc. It built up exposure in stocks several stocks from capital goods, engineering, power & infrastructure such as Ajax Engineering, Bharat Electronics, GE T&D, TD Power Systems. Other larger sectors in the portfolio are financials; while it holds the primary banks of ICICI, HDFC, and SBI, the fund also holds others from the financial sector such as CAMS, BSE, Care Ratings, and Aadhar Housing Finance.

As a result of its frequent changes, the fund’s portfolio churn is among the highest compared to other special opportunities funds or multicap funds. 

Minimal overlap

WOC Special Opportunities has only about a 26% overlap with the Nifty 500 index and a 24% overlap with the Nifty 500 Multicap index. It also shares a low overlap with the other two opportunities funds in Prime Funds.

Apart from sharing minimal similarities with opportunities funds, WOC Special Opportunities is also different from funds in the traditional flexicap/multicap categories. This makes it a good addition to portfolios as it provides differentiation in both strategy and portfolio.

Good performance start

With an inception in June 2024, WOC Special Opportunities does not have much of a performance history to show. So far, on a 1-year rolling return basis, the fund beats the Nifty 500 Multicap 25:25:25 index (since it is mid-and-smallcap heavy) all the time. The average outperformance margin is a handsome 13 percentage points. This is a good show, compensating for the fund’s high active share and high-risk strategy. It also beats other opportunities funds. 

Of course, there aren’t too many 1-year periods given its short history. Breaking it down into 6-month periods can show if there is any slip in returns after an initial robust start. On this front, WOC Special Opportunities has held steady in outperformance. The table below shows the performance of the fund against other opportunities funds.

WOC Special Opportunities is also among the best performers in the crop of ‘new’ funds. In the past couple of years, there have been over 50 active equity funds launched (i.e., equity funds that are not index funds or sector-themed). Of these, WOC Special Opportunities is in the top quartile; this is also one of the reasons why we opted to dig further into this fund as opposed to the other new funds.

On the volatility front, WOC Special Opportunities is much more volatile than the Nifty 500 Multicap index. Volatility is also higher than Franklin India Opportunities or ICICI Pru Opportunities. However, on the positive side, WOC Special Opportunities is still able to contain downsides reasonably well. Based on rolling 1-month returns since its inception (the metric we usually consider for downsides), the fund scored similar to Franklin India Opportunities in downside capture. 

Risks and suitability

While WOC Special Opportunities has got off on a flying start, it is an extremely high-risk bet. The risks come from the following:

  • The underlying strategy which involves a mix of longer-term calls and cashing in on short-term opportunities. A flat or a falling market cycle may not always throw up such opportunities. The fund has obviously not been through a proper down-market yet. The strategy also requires the fund to consistently identify such opportunities, especially with the very large portfolio it has been maintaining so far.
  • The heavy mid-and-smallcap tilt which leaves it vulnerable to the inherent volatility and risks in such stocks.
  • The lack of a track record that makes it difficult to judge how sustainable performance is and how consistent it can be at beating peers and index. 

Therefore, the fund suits only high-risk investors who are willing to include new funds that are not yet tried-and-tested. It is also especially useful in larger portfolios of say Rs 25 lakh or more, where there is enough room to add more funds. However, keep allocation to the fund within 5-7% of your portfolio. Treat the fund as a tactical call presently, and not as part of your core portfolio, until it establishes a more consistent track record. Be prepared to make an exit if performance shows signs of faltering. 

WOC Special Opportunities can be paired with any Prime Fund or even with funds from the normal categories of largecap/flexicap/midcap etc. You can invest in it even if you hold other opportunities funds from Prime Funds. 

As mentioned at the start, in these markets, it is important to pick up fresh opportunities to complement the more traditional core of your portfolio. We have been looking at such opportunities and adding them to Prime Funds. We’ll continue to be on the lookout for such differentiated funds! 

General disclosures & disclaimers

More like this

17 thoughts on “Prime Fund Recommendation: A high-risk, off-beat equity fund”

  1. Good discussions, thanks to PI. Two points :
    1. May i request ICICI Pru Business Cycle Fund to be compared this WOC Special Opp. Fund.
    2. Further, it might be a good idea to create a New Kids List under PRIME PORTFOLIO of the funds from Helios, OldBridge, Zerodha, Groww & WOC. May be categorize MF houses into Less than 3 yrs existence & greater than 3 yrs..

    1. Nice idea 🙂 But we aren’t about to recommend funds from all new AMCs, much less put them all into a portfolio even if call it an at-your-own-risk portfolio! With regard to IPru Business Cycle, the observations are overall the same – low portfolio overlap, WOC is by far riskier. IPru business cycle is similar to IPru Opportunities in terms of market cap allocation, but the Opportunities fund has generally delivered better returns. – thanks, Bhavana

  2. Dear Bhavana
    I read and then re-read and then read a couple of times more the paragraph named ‘Defining Special Opportunities’. Then I went through the fund’s portfolio. Then again went back to ‘that’ paragraph a few times trying to find the correlation. Failed every time.

    I always thought a good fund analyst:
    • Suggests fund houses with long proven track records
    • Suggests funds with long proven track records
    • Suggests funds which have a well-defined investment strategy/philosophy and a track record of following their own strategy/philosophy
    • Suggests fund with lower churn
    • Rates long-term performance well above short-term performance
    • Rates all the above points well above a short-term outperformance

    This fund review (and a couple of others that came out lately) turns head-over-heals whatever we have learned from your team (and other experts over the last few decades) about fund selection.

    My personal opinion is that this fund is just high on momentum steroids (just like several other funds launched in the last 1 to 2 years under different names and categories) which works well for personally run stock portfolios, but may end up very badly for a mutual fund. So, I’ll keep my safe distance from this fund (and any other fund whose name itself smells of misleading tactics and mis-selling).

    I hold PI research team in very high regard, but this article is of the quality that I would expect from a new-age online brokerage or an influencer, not from PI.
    Best regards

    1. Thanks for the feedback, appreciate your point. So, the primary approach we follow for fund analysis and recommendations is as you said – wait for track record and consistency, look at portfolio churn and strategy, and look at downside containment. These are the criteria for our main recos in Equity Moderate & Aggressive. We wouldn’t ever put any fund that wasn’t properly established here.

      But we also need to adapt to changing situations. From what we have observed, the pure mid-cap or smallcap funds are not that great at adding return to a portfolio and in the past few years several of them drop and rise compared to the index. Market cycles are also much shorter and sector/stock shifts are also quicker. So for some funds that are less dynamic, that means a period of underperformance before there is a pick up, and we have seen this playing out in several funds.

      So, if one is looking for higher-return funds or to try to compensate for some underperformance through style diversification, there needs to be some options. This apart, momentum as a strategy is not entirely wrong. It can well be used in small doses in a portfolio and are in fact good complements to a buy-and-hold approach. Also, there are several new AMCs where approaches are fresh and waiting until a track record is established may mean missed opportunities.

      For these reasons we had, a few quarters ago, introduced a new section altogether in Prime Funds called High Risk where we housed such up-and-coming options. If these establish themselves, then we had the option of moving them to the main Prime Funds categories. We had added Kotak Multicap here some time ago before it hit a 3 year record and then moved it to the main Aggressive category. We’ve had Badhan Large-and-Mid here for some quarters now and it’s performance has held up – but we’d had JM Value here earlier and removed it as its outperformance started to flag. Because these funds are extremely high risk, we specifically say that allocations should be low so that any slip here, plus quick action to remove it, is not very detrimental to overall returns.

      Basically, the approach we’re trying to explain is to have the established funds as the main part of a portfolio, and use such funds as tactical or high-risk high-return opportunities to boost returns. Of course, this approach is not everyone’s cup of tea and are well avoidable 🙂 Requires a bit more active management, certainly. Hope this clarifies and explains how we look at fund recommendations. – thanks, Bhavana

  3. Thanks for the article. Will be looking forward to more such differentiated fund recommendations.

    A few questions:
    1. “You can invest in it even if you hold other opportunities funds from Prime Funds.”
    Is this because of the low overlap and the performance of the WOC fund, or is there any major difference between their strategies like say how they define a special opportunity?

    2. Looking at the volatility, if one had a lump sum, would you say they should go for a flexi STP based on the NAV (assuming it’s available) or a one-time full investment?

    3. On the portfolio level should there be a limit on the total number of (or percent allocation to) such high-risk funds?
    I understand that such calls will be few and far between, but is it ok to keep adding such funds till the time you give a sell call on any of them?

    1. 1. Both because of low overlap and the strategy. ICICI Pru for example is less aggressive and more buy-and-hold.
      2. Use SIPs/STPs for any lumpsum investments that are more than 4-5% of your entire portfolio. If the lumpsum is small, then there is limited benefit in SIPs
      3. As far as number of funds go – you need to first peg how much allocation you want in high-risk funds based on your timeframe & risk. Then you can decide the number of funds. Number of funds also depends on your investment amount – for larger amounts, you can have more funds. This article will give you an idea Don’t keep adding funds every time we give a recommendation, you will wind up with too many funds. Add funds only if they offer differentiation and only if your portfolio has the room to add more funds. – thanks, Bhavana

      1. Thanks.
        Just to confirm, when you say ‘4-5% of your entire portfolio’, you mean the entire equity portfolio, right? Or, is it inclusive of debt too, in the form of funds, PPF, NPS etc?

        1. It is part of your total portfolio – equity and debt. Of course you need to consider whether you already hold risky funds before venturing into these. Thanks, Vidya

  4. I have given up on Prime Stocks already. Because unless one has sharp expertise of the field already they will end up a “Prime Investor Equity Fund” if they follow the Prime Stocks, and they have sharp expertise they will not require Prime Funds.

    I am starting to feel the same about Prime Funds recommendations. How many funds one is supposed to invest in? When to switch/replace, when to dump and move on to something else or existing funds? Keep adding funds? How many? Is everything left to customer/user discretion? Or get yet another expert subscription on top of PI — like a fee only advisor, or PMS?

    And if one has a decent portfolio already should they exit PI altogether?

    Please don’t get me wrong — I am not blaming PI for doing any of this, I am just tying to make sense of it all as a low/mid net worth retail investor.

    1. We understand your point.

      To explain, we do not say that one should invest in every fund we recommend. Since we are a recommendation platform, we need to provide a variety of recommendations that cover different use cases. This is also why we give the suitability separately so that one can take a call on whether or not to invest. Recommendations are also made to highlight new opportunities, since there are several subscribers who want to know of such options; not everyone will want to maintain only a small set of funds.

      You can use our platform to maintain your portfolio, especially if you have active funds, since performance in these funds can always change. The Review Pro tool will also tell you if you have too many funds or if the asset allocation is going out of sync with what you need etc. We publish a variety of articles on the subject of markets and investments. – thanks, Bhavana

      1. Yes, I do use Review Pro tool it’s just that I do not sync is very often and do not look at it very often either (I in genera avoid looking at my portfolio too often, maybe I should).

        I was waiting for the, long awaited, stock import option (which I think there’s no ETA on) so that I could make PI as the one place where I track all of it – away from Kuvera (very buggy now) and VRO (I could never “get” this place).

        And I understand as a research and recommendation platform you have to do that – I was just thinking from the perspective of where should I stay. e.g (just an example; not seeking personal reco here) I am invested in ICICI Hybrid Aggressive and HDFC Bal Adv was recommended and I was not sure whether I should stay or move or get into both (increasing my portfolio size by one more). That kind of dilemma. That’s where I was coming from. Thanks for your response.

    1. No, we have not published a detailed report on this fund. We had added it in Prime Funds during the June quarter review, and we had given a brief rationale for this addition in the review report we wrote at that time. We have published this reco today to give a deeper explanation. – thanks, Bhavana

        1. That would be difficult to pinpoint exactly, since the fund does not disclose any such break up. We use our own judgement based on the stock and sector choices to know the nature of special situations the fund may take. – thanks, Bhavana

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Hold On

You are being redirected to another page,
it may take a few seconds.
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

Start registration

OR
user icon
user icon
user icon

Terms & Conditions

A copy of the T&C has been sent to your email.

Last modified on February 18, 2025

This website www.primeinvestor.in (“Website”) is owned and operated by PrimeInvestor Financial Research Pvt. Ltd. (“RA”), a SEBI-registered Research Analyst with Registration No. INH200008653.

Through the Website, the RA allows clients to access research recommendations, research reports, and model portfolios, along with tools, personal finance products, and articles, on the payment of a subscription fee (“Research Services”). The terms ‘RA’ or ‘us’ or ‘we’ refer to PrimeInvestor Financial Research Pvt Ltd (SEBI RA Registration No INH200008653) who are the owners of this Website and offering the Research Services. The term ‘you’ and ‘client’ refers to the subscriber of the Services on the Website. The RA provides the Research Services subject to the notices, terms, and conditions set forth in these Terms. By accepting these Terms when you subscribe to the Research Services, you provide your consent to abide by these Terms.

Most Important Terms and Conditions (MITC)

[Forming part of the Terms and Conditions for providing research services]

  1. These terms and conditions, and consent thereon are for the research services provided by the Research Analyst (RA) and RA cannot execute/carry out any trade (purchase/sell transaction) on behalf of the client. Thus, the clients are advised not to permit RA to execute any trade on their behalf.
  2. The fee charged by RA to the client will be subject to the maximum amount prescribed by SEBI/ Research Analyst Administration and Supervisory Body (RAASB) from time to time (applicable only for Individual and HUF Clients).
    Note:
    • SEBI's current cap on fee is Rs 1,51,000/- per annum per family of client for all research services of the RA.
    • The fee limit does not include statutory charges.
    • The fee limits do not apply to a non-individual client / accredited investor.
  3. RA may charge fees in advance if agreed by the client. Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter. In case of pre-mature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.
  4. Fees to RA may be paid by the client through any of the specified modes like cheque, online bank transfer, UPI, etc. Cash payment is not allowed. Optionally the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited (i.e. currently recognized RAASB).
  5. The RA is required to abide by the applicable regulations/ circulars/ directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.
  6. Any assured/guaranteed/fixed returns schemes or any other schemes of similar nature are prohibited by law. No scheme of this nature shall be offered to the client by the RA.
  7. The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services. All opinions, projections, estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation/publication of research report.
  8. Any investment made based on recommendations in research reports are subject to market risks, and recommendations do not provide any assurance of returns. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report. Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.
  9. The SEBI registration, Enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.
  10. For any grievances,
    • Step 1: the client should first contact the RA using the details on its website or following contact details:
      Customer care: [email protected]
      Grievance officer: [email protected], ATTN: Srikanth Meenakshi
      Compliance officer: [email protected], ATTN.: Bhavana Acharya
      Principal officer: [email protected], ATTN.: Vidya Bala
    • Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at www.scores.sebi.gov.in
    • Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
  11. Clients are required to keep contact details, including email id and mobile number/s updated with the RA at all times.
  12. The RA shall never ask for the client’s login credentials and OTPs for the client’s Trading Account, Demat Account, and Bank Account. Never share such information with anyone including RA.

By browsing, viewing, using the Website and subscribing to the Research Services provided therein you consent to and agree to comply with these Terms and Conditions of subscription (“Terms”).

The RA reserves the right to change or modify the Website, the contents thereof and these Terms at any time. All modifications to these Terms & Conditions will be posted on the Website and will become effective immediately upon such posting. Changes once made will be communicated to the client. Continued use of the Website shall be construed as acceptance of the revisions to the Terms by conduct.

The following terms and conditions include but are not limited to minimum mandatory terms and conditions to clients as stipulated by SEBI.

1. Availing the research services

By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research service of the RA at his/her sole discretion. The RA confirms that Research Services shall be rendered in accordance with the applicable provisions of the SEBI RA Regulations.

2. Obligations on RA

The RA shall be bound by the SEBI Act and all the applicable rules and regulations of SEBI, including the RA Regulations and relevant notifications of Government, as may be in force, from time to time.

3. Client Information and KYC

The client shall furnish all such details in full as may be required by the RA in its standard form with supporting details, if required, as may be made mandatory by Research Analyst Administration and Supervisory Body(RAASB)/SEBI from time to time. RA shall collect, store, upload and check KYC records of the clients with KYC Registration Agency (KRA) as specified by SEBI from time to time.

4. Standard Terms of Service

The consent of client shall be taken on the following understanding:

“I / We have read and understood the terms and conditions applicable to a research analyst as defined under regulation 2(1)(u) of the SEBI (Research Analyst) Regulations, 2014, including the fee structure.

I/We are subscribing to the research services for our own benefits and consumption, and any reliance placed on the research report provided by research analyst shall be as per our own judgement and assessment of the conclusions contained in the research report.

I/We understand that –

  1. Any investment made based on the recommendations in the research report are subject to market risk.
  2. Recommendations in the research report do not provide any assurance of returns.
  3. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.”

The declaration of the RA is as follows:

  1. We are duly registered with SEBI as an RA pursuant to the SEBI (Research Analysts) Regulations, 2014 and our registration details are: registration no SEBI INH200008653, with registration date 19th August, 2021
  2. We have the registration and qualifications required to render the services contemplated under the RA Regulations, and the same are valid and subsisting;
  3. Research analyst services provided by us do not conflict with or violate any provision of law, rule or regulation, contract, or other instrument to which it is a party or to which any of its property is or may be subject;
  4. The maximum fee that may be charged by the RA is ₹1.51 lakhs per annum per family of client. Our current fee structure, the term and duration of our subscription for our Research Services, can be viewed on our website here: https://primeinvestor.in/prime-pricing
  5. The recommendations provided by us as part of the Research Services do not provide any assurance of returns.

5. Consideration and mode of payment

The client shall duly pay to the RA the agreed fees for the services that RA renders to the client and statutory charges, as applicable. Such fees and statutory charges shall be payable through the specified manner and mode(s)/ mechanism(s).

The payment of fees shall be through a mode that shows traceability of funds. Such modes include but are not limited to credit cards/debit cards/ UPI/ net banking or any other mode specified by SEBI from time to time. However, the fees shall not be in cash.

6. Risk factors

  1. Investments are subject to market risk. Investing or trading in financial products involves risk. Past performance of the recommendation is not an indication of future returns. Past performance of the RA is not an indicator of future performance. Past performance of the security is not an indication of future returns.
  2. There are no assurances or guarantees that the objectives of any investment in financial products will be achieved.
  3. The names of financial products mentioned herein do not in any manner indicate their prospects or returns. The performance in the equity may be adversely affected by the performance of individual companies, changes in the market place and industry specific and macro-economic factors.
  4. The performance of the investments/ products recommended by the RA are subject to a wide range of risks, including but not limited to: performance of the respective companies, changes in equity and debt market conditions, micro and macro factors and forces affecting equity and debt markets, general levels of interest rates and interest rate risk, credit risk, liquidity risk, reinvestment risk, economic slowdown, volatility & illiquidity of the stocks, risks associated with trading volumes, liquidity and settlement systems in equity and debt markets and/or such other circumstance beyond the control of the RA or any of its Associates.
  5. Other risk factors include that may affect the performance of the investments/ products recommended by the RA include but are not limited to economic policies, changes of Government and its policies, acts of God, acts of war, civil disturbance, sovereign action and /or such other acts/ circumstance beyond the control of the RA or any of its Associates.
  6. The recommendations provided by the RA as part of its Research Services may not be suitable to all categories of investors.
  7. The client should read all scheme and security related documents carefully before investing.
  8. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

7. Conflict of interest

The RA shall adhere to the applicable regulations/ circulars/directions specified by SEBI from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

General disclosures: PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). PrimeInvestor Financial Research Pvt. Ltd., its employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.

Restrictions on trading: To ensure no conflict of interest, the RA declares as follows:

  1. Personal trading activities of the individuals employed as research analysts shall be monitored, recorded and subject to a formal approval by the directors or compliance officer of PrimeInvestor Financial Research Private Limited.
  2. Research analysts employed by PrimeInvestor Financial Research Private Limited or their associates or relatives shall not:
    • Deal/ trade in stocks recommended/ tracked by the research analyst within 30 days before and five days after the publication of a research report;
    • Deal/ trade in securities that the research analyst reviews in a manner contrary to the given recommendation;
    • Purchase or receive securities of the issuer before the issuer's initial public offering, if the issuer is principally engaged in the same types of business as companies that the research analyst follows or recommends.

Disclosures with respect to Research and Recommendations Services:

  1. The RA or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation.
  2. The RA, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its Research Services or investment information.
  3. The Research Analysts who have prepared the research reports that form part of the Research Services (“Research Analyst”) certify that all of the views expressed in the research report accurately reflect their views about the subject company or subject security.
  4. The RA or directors or employees or Research Analyst certify that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
  5. The Research Analyst has not served as director, officer or employee in the subject company, AMC or insurance company of the mutual fund or insurance policy that is the subject of this report, or company whose bonds, NCDs, fixed deposits or other savings products that is the subject of this report.
  6. The Research Analyst or their relatives do not have any known direct or indirect material conflict of interest including long/short positions in the subject company.
  7. The Research Analyst may hold investments in the stocks, mutual fund schemes, bonds, fixed deposits, insurance policies, or other products that are the subject of the recommendations provided as part of the Research Services. The Research Analyst certifies that they will not act in a manner contrary to their views on these securities except in the event of significant news or event or change in personal financial circumstances and without formal approval from the directors of PrimeInvestor Financial Research Pvt. Ltd. or the compliance officer.
  8. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of the Research Services. Such conflict of interest shall be disclosed to the client as and when they arise.
  9. The RA or its directors or its employee or its associates have not managed or co-managed the public offering of any company. The RA or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. The RA or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. The RA or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
  10. The subject company of its research recommendations was not a client of the RA or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided.
  11. The RA or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.

PrimeInvestor Financial Research Pvt. Ltd., its Associates, the Research Analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies)? – NO

8. Termination of service and refund of fees:

The RA may terminate or suspend rendering of Research Services to the client in the following circumstances:

  1. On account of suspension/cancellation of registration of RA by SEBI. In case of suspension of certificate of registration of the RA for more than 60 (sixty) days or cancellation of the RA registration, RA shall refund the fees, on a pro rata basis for the period from the effective date of cancellation/ suspension to end of the client’s subscription period.
  2. The RA voluntarily chooses to terminate its Research Service. In the event of such termination of the Research Service, the RA shall refund the fees, on a pro rata basis for the period from the date of such termination of research service to end of the client’s subscription period.

9. Grievance redressal and dispute resolution:

Any grievance related to:

  1. nonreceipt of research report, or
  2. missing pages or inability to download the entire report, or
  3. any other deficiency in the research services provided by RA

shall be escalated promptly by the client to the person/employee designated by RA, in this behalf as under:

Name: Bhavana Acharya
Designation: Director & Compliance Officer, PrimeInvestor Financial Research Pvt Ltd
Email: [email protected]

The RA shall be responsible to resolve grievances within 7 (seven) business working days or such timelines as may be specified by SEBI under the RA Regulations.

RA shall redress grievances of the client in a timely and transparent manner. Any dispute between the RA and his client may be resolved through arbitration or through any other modes or mechanism as specified by SEBI from time to time.

If the client is not satisfied with the response of the RA, he/she can lodge his/her grievances with SEBI at scores.sebi.gov.in. Alternatively, the client may also write to any of the offices of SEBI. For any queries, feedback or assistance, please contact SEBI Office on Toll Free Helpline at 1800 22 7575 / 1800 266 7575

Details on grievances are available on the Website as follows: https://primeinvestor.in/ra-grievance/

10. Additional clauses:

Scope of the Research Service: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Services are not meant to be tailor-made or customized solutions that specifically apply to each client based on his/her risk profile.

The RA never guarantees the returns on the recommendation provided. Investor shall take note that investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The RA shall not be responsible for any loss to the Investors.

This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.

The Research Service, including recommendations, research reports, updates, and other information will be accessible through the RA’s website https://primeinvestor.in only. Such recommendations and updates will not be provided over phone calls.

Fees: Our current fee structure, the term and duration of our subscription for our Research Service, can be viewed on our website: https://primeinvestor.in/prime-pricing. Eligibility for any discounts is ascertained at the time the client subscribes. Any such discount and its tenure shall be at the discretion of the RA.

Subscription and access to content services fall under the purview of Goods and Services Tax (GST) as per the current indirect taxation policy, Government of India. Unless otherwise indicated, prices stated on our website are exclusive of applicable GST, any applicable value added tax (VAT) or other sales taxes. We are a business-to-consumer (B2C) service provider and we do not commit to provide any input tax credit on GST charged on subscription to our Research Service.

We may change the Subscription Fees and charges then in effect, or add new fees or charges which will take effect at the end of the client’s subscription period, by giving notice in advance and an opportunity to cancel renewal of the subscription.

Subscription Access & Renewal: Subscription to the Website commences immediately on the realisation of payment of the Subscription Fees. Subscriptions are set to be renewed automatically at the end of the subscription period.

Unless the client notifies us before the end of his/her subscription period, or the client cancels the auto-renewal mandate within the period specified by law, that the client does not wish to renew his/her subscription, the client’s subscription will renew for the period defined by the client’s subscription plan. We will charge the subscription using the same payment method that you previously used.

Although the client may notify to us his/her intention to his/her subscription, such notice will only take effect at the end of his/her then current subscription period, and he/she will not receive a refund other than as set out under Clause 8 in these Terms.

The client may notify us of his/her wish to cancel his/her subscription by sending an email to [email protected]. The client must provide at least 5 business days advance notice for this to be implemented.

Refunds: There can be no cancellation and refund of subscription fee paid once the subscription is active, other than as stated in Clause 8 of these Terms. If the client is entitled to a refund as specified under Clause 8 of these Terms, the RA will credit that refund to the card or other payment method used by the client to submit payment, unless it has expired - in which case the RA will contact the client to proceed with the refund. If we do issue a refund or credit due to circumstances outside the obligations specified under Clause 8, we are under no obligation to issue the same or a similar refund in the future.

General disclaimers: The recommendations made herein in the Research Services are expression of views and/or opinions and should not be deemed or construed to be advice for the purpose of purchase or sale of any security, nor a solicitation or offering on any investment/ trading opportunity on behalf of the company, AMC, insurance company, or issuer of security referred to herein.

The content and research reports generated by the RA does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities.

The information/ opinion/ views mentioned in research reports or by the RA are not meant to serve as a professional guide to the client or recipients of this Report. The research report, recommendation, or any other content published by the RA do not assure or guarantee any minimum or fixed returns to the client or recipients of the reports/ recommendations/ content.

Use of this information is at the client’s own risk. The client must make his/ her own investment decisions based on his/her specific investment objective and financial position and using such independent advisors as he/she believes necessary. The services rendered by the RA are on a best-effort basis. All information in the content or research report of the RA is provided on an as is basis. Information is believed to be reliable but the RA does not warrant its completeness or accuracy and expressly disclaim all warranties and conditions of any kind, whether express or implied.

While due care has been taken to ensure that the disclosures, information, and opinions given are fair and reasonable, PrimeInvestor Financial Research Pvt Ltd and/or none of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information/ opinions/ views contained in the research report and recommendations that form part of the Research Service, and/or mails, social media or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

Any agreements, transactions or other arrangements made between the client and any third party named on (or linked to from) the Website are at your own responsibility and entered into at your own risk. Any information that you receive via the Website, whether or not it is classified as “real time”, may have stopped being current by the time it reaches you. Market price information may be rounded up/down and therefore may not be entirely accurate.

The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research Services before onboarding.

History, present business and background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services.

Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made thereunder against the Research Analyst relating to Research Analyst services.

Details of the RA's associates: No associates.

Usage of Website Content: This Website is controlled and operated by the RA. All material, including research reports, recommendations, portfolios, ratings, lists of financial products, illustrations, statements, opinions, views, photographs, products, images, artwork, designs, text, graphics, logos, button icons, images, audio and video clips and software (collectively, “Content”) are protected by copyrights, trademarks and other intellectual property rights that are owned and controlled by the RA or by other parties that have licensed their material to us.

Except where otherwise agreed in writing with the RA, material on the Website is solely for the client’s personal, non-commercial use. Except as provided below, the client must not copy, reproduce, republish, upload, post, transmit or distribute such material in any way, including by e-mail or other electronic means and whether directly or indirectly and the client must not assist any other person to do so.

Without the prior written consent of the RA, modification of the materials, use of the materials on any other web site or networked computer environment or use of the materials for any purpose other than personal, non-commercial use is a violation of the copyrights, trademarks and other proprietary rights, and is prohibited. Any use for which the client receives any remuneration, whether in money or otherwise, is a commercial use for the purposes of these Terms.

The client may occasionally distribute a copy of a research report, or a portion of the same, from the Website in non-electronic form to a few individuals without charge, provided the client includes all copyright and other proprietary rights notices in the same form in which the notices appear, original source attribution, and the phrase “Used with permission from PrimeInvestor Financial Research Pvt. Ltd.”

While the client may occasionally download and store research reports or information from the Website for his/her personal use, he/she may not otherwise provide others with access to the same. The foregoing does not apply to any sharing functionality we provide through the Website that expressly allows the client to share Content or links to Content with others. In addition, the client may not use Content he/she has downloaded for personal use to develop or operate an automated trading system or for data or text mining.

The client agrees not to rearrange or modify the Content available through the Website. The client agrees not to display, post, frame, or scrape the Content for use on another website, app, blog, product or service, except as otherwise expressly permitted by these Terms. You agree not to create any derivative work based on or containing the research products and Content. The framing or scraping of or in-line linking to the Services or any Content contained thereon and/or the use of webcrawler, spidering or other automated means to access, copy, index, process and/or store any Content made available on or through the Services other than as expressly authorized by us is prohibited.

The client further agrees to abide by exclusionary protocols (e.g., Robots.txt, Automated Content Access Protocol (ACAP), etc.) that may be used in connection with the Research Services. The client may not access parts of the Research Services to which he/she is not authorized, or attempt to circumvent any restrictions imposed on your use or access of the Services.

As a general rule, the client may not use the Content, including without limitation, any Content made available through one of our RSS Feeds, in any commercial product or service, without our express written consent.

The client may not create apps, extensions, or other products and services that use our Content without our permission. The client may not aggregate or otherwise use our Content in a manner that could reasonably serve as a substitute for a subscription to the Website.

The client may not access or view the Services with the use of any scripts, extensions, or programs that alter the way the Services are displayed, rendered, or transmitted to you without our written consent.

The client agrees not to use the Services for any unlawful purpose. We reserve the right to terminate or restrict the client's access to the Website if, in our opinion, the client's use of the Services may violate any laws, regulations or rulings, infringe upon another person's rights or violate these Terms.

Prohibited content: The Website includes comments sections, blogs and other interactive features that allow interaction among clients and between clients and the RA. We call the information posted by or contributed by users “Contributed Content.” In the course of availing of the Research Services or uploading any post or comment on the Website, the client shall not post any Contributed Content that (i) contains nude, semi-nude, sexually suggestive photos, (ii) tends or is likely to abuse, harass, threaten, impersonate or intimidate other users of the Website and/or Research Services, (iii) is lascivious or appeals to the prurient interest or if its effect is such as to tend to deprave and corrupt persons who are likely to use or have access to the Website and/or Services, or (iv) otherwise violates, is prohibited or restricted by applicable law, rule or regulation, is offensive or illegal or violates the rights of, harms or threatens the safety of other users of the Website and/or Services (collectively “Prohibited Content”).

We reserve the right to cease to provide the client with the Research Services or access to the Website, or terminate your subscription, with immediate effect and without notice and liability, for violating these Terms, applicable law, rules or regulations and reserves the right to remove Prohibited Content which is in violation of these Terms, or is otherwise abusive, illegal or disruptive. The determination of whether any content constitutes Prohibited Content, violates these Terms, or is otherwise abusive illegal or disruptive, is subject to the sole determination of the Firm.

Changes to Research Services: We are constantly endeavouring to improve the quality of Research Services provided to our clients. Due to this, the form and nature of the Research Services provided may change from time to time without any prior notice to the client. We reserve the right to introduce and initiate new features, functionalities, components to the Website and/or Research Services and/or change, alter, modify, or discontinue existing ones without any prior notice to the client.

Warranty and liability disclaimer: The Website, Research Services, and all the materials and services, included on or otherwise made available to the client through this Website is provided by the RA on an “as is” and “as available” basis without any representation or warranties, express or implied except otherwise specified in writing. Without prejudice to the foregoing paragraph, the RA does not warrant that:

  • This Website and/or Research Services will be constantly available, or available at all;
  • The information on this Website or provided through the Research Services is complete, true, accurate or not misleading; or
  • The quality of any products, services, information, or other material that you obtain through the Website or Services will meet your expectations.

The RA, to the fullest extent permitted by law, disclaims all warranties, whether express or implied, including the warranty of merchantability, fitness for particular purpose and non-infringement. The RA makes no warranties about the accuracy, reliability, completeness, or timeliness of the Website, Research Services, Content, Contributed Content, Services, software, text, graphics and links.

The RA does not warrant that this Website, Research Services, information, content, materials, or any other material included on or otherwise made available to you through this Website, their servers, or electronic communication sent by the RA are free of viruses or other harmful components.

Nothing on this Website constitutes, or is meant to constitute, advice of any kind.

Indemnification: The client:

  1. Represents, warrants and covenants that no materials of any kind provided by him/her will:
    1. Violate, plagiarise, or infringe upon the rights of any third party, including copyright, trademark, privacy or other personal or proprietary rights; or
    2. Contain libellous, Prohibited Content or other unlawful material;
  2. Hereby agree to indemnify, defend and hold harmless the RA and all of the RA’s officers, directors, owners, agents, customers/clients, information providers, affiliates, licensors and licensees (collectively, the “Indemnified Parties”) from and against any and all liability and costs, including, without limitation, reasonable advocate’s fees, incurred by the Indemnified Parties in connection with any claim arising out of any breach by the client of these Terms or the foregoing representations, warranties and covenants. The client shall cooperate as fully as reasonably required in the defence of any such claim. The RA reserves the right, at its own expense, to assume the exclusive defence and control of any matter subject to indemnification by the client.

Applicable law: This Website, including the Content and Contributed Content and information contained herein, and the provision of Research Services shall be governed by the Securities and Exchange Board of India, laws of the Republic of India and the courts of Chennai, India which shall retain exclusive jurisdiction to entertain any proceedings in relation to any disputes arising out of the same. As such, the laws of India shall govern any transaction completed using this Website.

Information gathered and tracked: Information submitted or collected on the Website or pursuant to the use of the Services is stored in a database. Specifically, we store the username, name, e-mail address, contact number, as submitted or collected on our Website or through the provision of the Research Services. We may use such information to send out occasional promotional materials, including alerts on new Services available, or other promotional and marketing material relating to our clients and customers.

In accordance with the Information Technology Act 2000, the name and the details of the Grievance Officer at PrimeInvestor is provided below:

Mr. Srikanth Meenakshi
PrimeInvestor Financial Research Pvt. Ltd., Registered office: 659, 4th Avenue, D-Sector, Anna Nagar Western Extension, Chennai 600 101.
Email: [email protected]

11. Mandatory notice:

Clients shall be requested to go through Do’s and Don’ts while dealing with RA as specified in SEBI master circular no. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 or as may be specified by SEBI from time to time.

12. Optional Centralised Fee Collection Mechanism:

SEBI has operationalized a centralized fee collection mechanism for IA and RA. Under this mechanism, clients shall pay fees to IAs/RAs through a designated platform/portal administered by a recognized Administration and Supervision body. This is an optional mechanism for the registered entities. At this time, PrimeInvestor has opted out of this fee collection mechanism. Therefore, all subscription payments for the Research Services will be through the modes as specified in Clause 5 of these Terms.

Enter the OTP sent to (Edit)
By doing this you agree to our terms & conditions
Didn't receive OTP? Resend

comHi,

Registration Sucessful

Your 7-day Free Trial has started


comVerify your KYC

Unlock coupon 10% discount code

user icon
user icon
user icon
Skip for now

comHi,

Registration Sucessful

Your 7-day Free Trial has started


comKYC Verified

Discount Unlocked

com

*Applicable only on our Annual Subscription plans

Coupon will be auto applied during checkout

Skip for now
Have an account?
Login To Your Account
OR
Don’t have an account ? Register for free